These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6259592)

  • 1. [In vitro activity of cefotaxime on anaerobes (author's transl)].
    Soussy CJ; Thibault M; Duval J
    Nouv Presse Med; 1981 Feb; 10(8):556-8. PubMed ID: 6259592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Susceptibility of anaerobic bacteria to cefoxitin (author's transl)].
    Freydière AM; Gille Y; Marcel JP; Vincent P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1793-5. PubMed ID: 6256880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of cefotetan against anaerobic bacteria].
    Sedallian A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B; Naden MG
    Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B; Naden MG
    J Chemother; 1989 Jul; 1(4 Suppl):106-7. PubMed ID: 16312326
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of ceftizoxime against anaerobic bacteria and comparison with other cephalosporins.
    Chow AW; Finegold SM
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():45-50. PubMed ID: 6296028
    [No Abstract]   [Full Text] [Related]  

  • 8. Susceptibility of anaerobic bacteria to cefoperazone and other beta-lactam antibiotics.
    Jacobus NV; Tally FP; Barza M; Gorbach SL
    Clin Ther; 1980; 3(Spec Issue):34-8. PubMed ID: 6446396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial effects of niridazole. II. Effects on aerobic and anaerobic bacteria].
    Hof H; Müller KM
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):265-71. PubMed ID: 6299027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple tube test for assessing antibiotic sensitivity of certain anaerobic bacteria.
    Shivers WF; Graber CD
    J Egypt Med Assoc; 1976; 59(1-2):150-4. PubMed ID: 1032368
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of cefotaxime against enterobacteriaceae. Comparison with cephalothin, cefazolin, cefamandole, cefoxitin and cefuroxime on 117 strains isolated from neutropenic patients (author's transl)].
    Tancrede C; Mariel C; Chaigneau H; Eveno J
    Nouv Presse Med; 1981 Feb; 10(8):545-7. PubMed ID: 6259589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia.
    Arzese A; Skerlavaj B; Tomasinsig L; Gennaro R; Zanetti M
    J Antimicrob Chemother; 2003 Sep; 52(3):375-81. PubMed ID: 12917245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity and synergism of cefuroxime on anaerobic bacteria.
    Thadepalli H; White DW; Bach VT
    Chemotherapy; 1981; 27(4):252-8. PubMed ID: 7249787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 May; 17(5):901-4. PubMed ID: 6249198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antibacterial activity of the new cephalosporin cefcanel against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):550-1. PubMed ID: 2548866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of anaerobes to cefoxitin and other cephalosporins.
    Tally FP; Jacobus NV; Bartlett JG; Gorbach SL
    Antimicrob Agents Chemother; 1975 Feb; 7(2):128-32. PubMed ID: 1137364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative in vitro activity of ofloxacin (RU 43 280) and other quinolone derivatives against 722 bacteria of clinical interest.
    Santos Ferreira M; Vital J
    Chemioterapia; 1987 Jun; 6(2 Suppl):145-7. PubMed ID: 2908239
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.
    Drulak MW; Chow AW
    Antimicrob Agents Chemother; 1981 Nov; 20(5):683-5. PubMed ID: 6275782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.